Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
4 trials
Recent
Start date
Enrollment
Phase 2
×
Sarcoma
×
regorafenib
×
Clear all
Filters
3
NCT03793361
2026-03-18
EREMISS
Centre Oscar Lambret
Phase 2
Completed
127 enrolled
NCT01900743
2026-03-13
REGO-SARC
Centre Oscar Lambret
Phase 2
Completed
219 enrolled
NCT05582031
2023-06-07
REFIT-MSS
Translational Research in Oncology
Phase 2
Withdrawn
NCT02307500
2022-09-10
RESOUND
Istituto Clinico Humanitas
Phase 2
Completed
82 enrolled